Time to clinical stability in patients hospitalized with community- acquired pneumonia: Implications for practice guidelines

JAMA

Volumn 279, Issue 18, 1998, Pages 1452-1457

  Halm, Ethan A ^a   Fine, Michael J ^b   Marrie, Thomas J ^c   Coley, Christopher M ^d   Kapoor, Wishwa N ^b   Obrosky, D Scott ^b   Singer, Daniel E ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; MACROLIDE; PENICILLIN DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; FEMALE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

EID: 0032513753     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.18.1452     Document Type: Article

References (41)

1. Medicare and Medicaid statistical supplement, 1995. Health Care Finance Rev. September 1995; 16.
2. Weitzman S, Heimer D, Naggan L, Bar-Ziv G, Glick S. Uncomplicated pneumonia: an evaluation of determinants of length of hospitalization. Isr J Med Sci. 1983;19:591-595.
3. Wennberg JE, Frieman JL, Culp WJ. Are hospital services rationed in New Haven or over-utilized in Boston? Lancet. 1987;1:1185-1189.
4. McMahon LF, Wolfe RA, Tedeschi PJ. Variations in hospital admissions among small areas: a comparison of Maine and Michigan. Med Care. 1989; 27:623-631.
5. Cleary P, Greenfield S, Mulley AG, et al. Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA. 1991;266:73-79.
6. Fine MJ, Singer DE, Phelps AL, Hanusa BH, Kapoor WN. Differences in length of stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care. 1993;31:371-380.
7. Burns L, Wholey D. The effects of patient, hospital and physician characteristics on length of stay and mortality. Med Care. 1991;29:225-271.
8. McCormick D, Singer DE, Coley CM, et al. Variation in length of hospital stay in patients with community acquired pneumonia: are shorter stays associated with worse medical outcomes? J Gen Intern Med. 1996;11(suppl):72.
9. Fine MJ, Medsger AR, Stone R, et al. The hospital discharge decision in patients with community-acquired pneumonia: results from the pneumonia PORT cohort study. Arch Intern Med. 1997;157:47-56.
10. Voluntary Hospitals of America. Examining Pneumonia: An Analysis of Cost, Quality, and Clinical Issues. Irving, Tex: Voluntary Hospitals of America; 1993.
11. Bartlett JG, Mundy L. Community-acquired pneumonia. N Engl J Med. 1995;333:1618-1624.
12. Weingarten SR, Riedinger MS, Varis G, et al. Identification of low-risk hospitalized patients with pneumonia. Chest. 1994;105:1109-1115.
13. Fine MJ, Hanusa BH, Lave JR, et al. Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med. 1995;10:359-368.
14. Fine MJ, Auble TE, Yealy DM, et al. Improving the appropriateness of hospital care in community-acquired pneumonia: a prediction rule to identify patients at low risk for mortality and other adverse medical outcomes. N Engl J Med. 1997;336:243-250.
15. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-1636.
16. Kelleher C. Relationship of physician ratings of severity of illness and difficulty of clinical management to length of stay. Health Serv Res. 1993;27: 841-855.
17. Fang GD, Fine MJ, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine. 1990;69: 307-316.
18. Kaplan EL, Meier P. Nonparametnc estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
19. Allison P. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute; 1995.
20. Fine MJ, Hough LJ, Medsger AR, et al. The hospital admission decision for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team Cohort Study. Arch Intern Med. 1997;157:36-44.
21. Douglas RM, Devitt L. Pneumonia in New Guinea. Med J Aust. 1973;1:42-49.
22. Lieberman D, Porath A, Schlaeffer F, Lieberman D, Boldur I. Legionella species community-acquired pneumonia. Chest. 1996;109:1243-1249.
23. Nordstrom K, Kallings I, Dahnsjo H, Clemens F. An outbreak of legionnaires' disease in Sweden: report of sixty-eight cases. Scand J Infect Dis. 1983; 15:43-55.
24. Finkelstein M, Petkun W, Freedman M, Antopol S. Pneumococcal bacteremia in adults: age-dependent differences in presentation and outcome. J Am Geriatr Soc. 1983;31:19-27.
25. Esposito A. Community-acquired bacteremic pneumococcal pneumonia. Arch Intern Med. 1984; 144:945-948.
26. Ortqvist A, Grepe A, Julander I, Kalin M. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasmal pneumonias. Scand J Infect Dis. 1988;20:163-171.
27. Weingarten SR, Riedinger MS, Hobson P, et al. Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med. 1996;153:1110-1115.
28. Daifuku R, Movahhed H, Fotheringham N, Bear MB Nelson S. Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia. Respir Med. 1996;90:587-592.
29. Tunis SR, Hayward RS, Wilson MC et al. Internists's attitudes about clinical practice guidelines. Ann Intern Med. 1994;120:956-963.
30. Fein AM, Niederman MS. Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster? Am J Respir Crit Care Med. 1995;152:1149-1153.
31. Pearson S, Lee TH. Critical pathways: a primer. Ann Intern Med. 1995;123:941-948.
32. Quintiliani R, Cooper BW, Briceland LL, Nightingale CH. Economic impact of streamlining antibiotic administration. Am J Med. 1987;82:269-274.
33. Khan FA, Basir R. Sequential intravenous-oral administration of ciprofloxacin versus ceftezidime in serious bacterial respiratory tract infections. Chest. 1989;96:453-456.
34. Sanders WE, Morris JF, Alessi P, et al. Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with "usual care" in a multi-center clinical trial. Am J Med. 1991;91:261-266.
35. Ehrenkranz NJ, Nerenberg DE, Shultz JM Slater KC. Intervention to discontinue parenteral antimicrobial therapy in patients hospitalized with pulmonary infections: effect on shortening; patient stay. Infect Control Hosp Epidemiol. 1992;13:21-25.
36. Ramirez J A, Srinath L, Ahkee S, Huang A, Raff MJ. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med. 1995;155:1273-1276.
37. Siegel RE, Halpern NA, Almenoff PL, et al. A prospective randomized study of inpatient IV antibiotics for community-acquired pneumoiua: the optimal duration of therapy. Chest. 1996;110:965-971.
38. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patents. Chest. 1992;101:1005-1012.
39. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis. 1994;18:501-515.
40. Selker HP, BeshanskyJR, Pauker SG, Kassirer JP. The epidemiology of delays in a teaching hospital: the development and use of a tool that detects unnecessary hospital days. Med Care. 1989;27:112-129.
41. Selker HP. Criteria for adoption in practice of medical practice guidelines [editorial]. Am J Cardiol. 1993;71:339-341.